Vibativ®, Acetadote®, Caldolor® and Methotrexate Update


Earlier this year, we announced a strategic review following our accelerated business development activities, that led toa series of transactions. Because of that progress, we took a fresh look at our portfolio, partners and organization to ensure we havethe proper focus and capabilities going forward. Below is a summary of our findings and decisions: